Andres H Rossi
Overview
Explore the profile of Andres H Rossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguirre F, Marro M, Rodriguez P, Rall P, Miglietta E, Miranda L, et al.
Cad Saude Publica
. 2024 Oct;
40(9):e00155023.
PMID: 39417469
This study evaluated the explanatory factors of humoral immune response in older adults admitted to long-term care institutions in Buenos Aires, Argentina, up to 180 days after vaccination. An open-label,...
2.
De Niz M, Escobedo Garcia R, Teran Ramirez C, Pakowski Y, Abonza Y, Bialy N, et al.
J Microsc
. 2024 May;
294(3):420-439.
PMID: 38747464
In September 2023, the two largest bioimaging networks in the Americas, Latin America Bioimaging (LABI) and BioImaging North America (BINA), came together during a 1-week meeting in Mexico. This meeting...
3.
Saura-Sanchez M, Gomez-Ocampo G, Pereyra M, Barraza C, Rossi A, Cordoba J, et al.
Plant Physiol
. 2024 Apr;
195(3):2443-2455.
PMID: 38620015
Shade avoidance syndrome is an important adaptive strategy. Under shade, major transcriptional rearrangements underlie the reallocation of resources to elongate vegetative structures and redefine the plant architecture to compete for...
4.
Rodriguez P, Silva A, Miglietta E, Rall P, Pascuale C, Ballejo C, et al.
Front Immunol
. 2022 Oct;
13:992370.
PMID: 36225925
The COVID-19 pandemic has particularly affected older adults residing in nursing homes, resulting in high rates of hospitalisation and death. Here, we evaluated the longitudinal humoral response and neutralising capacity...
5.
Sosa S, Rossi A, Szalai A, Klinke S, Rinaldi J, Farias A, et al.
Nanoscale Adv
. 2022 Sep;
1(5):1833-1846.
PMID: 36134238
Engineering oligomeric protein self-assembly is an attractive approach to fabricate nanostructures with well-defined geometries, stoichiometry and functions. The homodecamer Lumazine Synthase (BLS) is a highly stable and immunogenic protein nanoparticle...
6.
Pascuale C, Varese A, Ojeda D, Pasinovich M, Lopez L, Rossi A, et al.
Cell Rep Med
. 2022 Aug;
3(8):100706.
PMID: 35926505
Heterologous vaccination against coronavirus disease 2019 (COVID-19) provides a rational strategy to rapidly increase vaccination coverage in many regions of the world. Although data regarding messenger RNA (mRNA) and ChAdOx1...
7.
Oviedo Rouco S, Rodriguez P, Miglietta E, Rall P, Gonzalez Lopez Ledesma M, Varese A, et al.
Lancet Infect Dis
. 2022 Jul;
22(8):1118-1119.
PMID: 35777383
No abstract available.
8.
Sanchez L, Oviedo Rouco S, Pifano M, Ojeda D, Pascuale C, Mazzitelli B, et al.
Lancet Infect Dis
. 2022 Mar;
22(5):589-590.
PMID: 35305316
No abstract available.
9.
Gonzalez Lopez Ledesma M, Sanchez L, Ojeda D, Oviedo Rouco S, Rossi A, Varese A, et al.
mBio
. 2022 Jan;
13(1):e0344221.
PMID: 35073758
Recent studies have shown a temporal increase in the neutralizing antibody potency and breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent individuals. Here, we examined longitudinal antibody responses...
10.
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
Rossi A, Ojeda D, Varese A, Sanchez L, Gonzalez Lopez Ledesma M, Mazzitelli I, et al.
Cell Rep Med
. 2021 Jul;
2(8):100359.
PMID: 34308389
Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, the limited supply and uneven vaccine distribution create an urgent need to optimize vaccination strategies. We evaluate SARS-CoV-2-specific...